{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:17:24Z","timestamp":1790273844239,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,18]],"date-time":"2017-02-18T00:00:00Z","timestamp":1487376000000},"content-version":"vor","delay-in-days":414,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1038\/mtm.2016.37","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T17:02:26Z","timestamp":1467219746000},"page":"16037","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease"],"prefix":"10.1016","volume":"3","author":[{"given":"Piotr","family":"Hadaczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Ciesielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Sudhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Samaranch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Pivirotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bringas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"O'Riordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Mastis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldy","family":"San Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Forsayeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystof S","family":"Bankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamya S","family":"Shihabuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtm.2016.37_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0270(00)00183-7","article-title":"Adeno-associated virus vectors: activity and applications in the CNS","volume":"98","author":"Peel","year":"2000","journal-title":"J Neurosci Methods"},{"key":"10.1038\/mtm.2016.37_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/hum.2008.151","article-title":"Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response","volume":"20","author":"Hadaczek","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib3","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","article-title":"Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system","volume":"97","author":"Davidson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/mtm.2016.37_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/hum.2013.005","article-title":"Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates","volume":"24","author":"Samaranch","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fncel.2013.00106","article-title":"Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors","volume":"7","author":"Merienne","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1038\/mtm.2016.37_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/mt.2009.216","article-title":"Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates","volume":"18","author":"Dodiya","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hum.2006.178","article-title":"Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain","volume":"18","author":"Taymans","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/2010.8.JNS091583","article-title":"Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation","volume":"114","author":"Sanchez","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1038\/mtm.2016.37_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jviromet.2011.10.004","article-title":"Transduction of striatum and cortex tissues by adeno-associated viral vectors produced by herpes simplex virus- and baculovirus-based methods","volume":"179","author":"Zhang","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1038\/mtm.2016.37_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/mt.2012.167","article-title":"Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses","volume":"21","author":"Ciesielska","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/mt.2013.266","article-title":"AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction","volume":"22","author":"Samaranch","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib12","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtm.2016.37_bib13","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtm.2016.37_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/hum.2013.200","article-title":"Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Stanek","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","article-title":"Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features","volume":"113","author":"Han","year":"2010","journal-title":"J Neurochem"},{"key":"10.1038\/mtm.2016.37_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","article-title":"Huntington disease models and human neuropathology: similarities and differences","volume":"115","author":"Vonsattel","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1038\/mtm.2016.37_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1038\/mtm.2016.37_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtm.2016.37_bib21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mt.2013.289","article-title":"Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice","volume":"22","author":"Dufour","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000323544","article-title":"Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain","volume":"89","author":"Richardson","year":"2011","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1038\/mtm.2016.37_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1227\/NEU.0b013e318217217e","article-title":"T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery","volume":"69","author":"Richardson","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1038\/mtm.2016.37_bib25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/mt.2011.11","article-title":"Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease","volume":"19","author":"Richardson","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/exnr.2000.7408","article-title":"Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach","volume":"164","author":"Bankiewicz","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1038\/mtm.2016.37_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneumeth.2010.12.022","article-title":"Design of an in-dwelling cannula for convection-enhanced delivery","volume":"196","author":"Rosenbluth","year":"2011","journal-title":"J Neurosci Methods"},{"key":"10.1038\/mtm.2016.37_bib28","doi-asserted-by":"crossref","first-page":"e76310","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mtm.2016.37_bib29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2015.048","article-title":"Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors","volume":"26","author":"Burnham","year":"2015","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mtm.2016.37_bib31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nbd.2015.03.023","article-title":"Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with \u03b1-synucleinopathies","volume":"78","author":"Bartus","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mtm.2016.37_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/156652311795684759","article-title":"Adeno-Associated Virus (AAV) Vectors in the CNS","volume":"11","author":"McCown","year":"2011","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JHD-130050","article-title":"Large genetic animal models of Huntington's Disease","volume":"2","author":"Morton","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.1038\/mtm.2016.37_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","article-title":"Huntington's disease - neuropathology","volume":"100","author":"Vonsattel","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1038\/mtm.2016.37_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mtm.2016.37_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neures.2014.09.002","article-title":"Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex","volume":"93","author":"Watakabe","year":"2015","journal-title":"Neurosci Res"},{"key":"10.1038\/mtm.2016.37_bib37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/mt.2009.286","article-title":"Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain","volume":"18","author":"Markakis","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/hum.2006.17.291","article-title":"Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain","volume":"17","author":"Hadaczek","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/mthe.2001.0520","article-title":"Targeted retrograde gene delivery for neuronal protection","volume":"5","author":"Kaspar","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ymthe.2005.01.011","article-title":"AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease","volume":"11","author":"Passini","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib42","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1073\/pnas.0810682106","article-title":"Efficient gene therapy-based method for the delivery of therapeutics to primate cortex","volume":"106","author":"Kells","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtm.2016.37_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.mt.6300367","article-title":"Efficient retrograde neuronal transduction utilizing self-complementary AAV1","volume":"16","author":"Hollis","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib44","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/hum.2013.189","article-title":"Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transport","volume":"25","author":"Castle","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/hum.2011.162","article-title":"Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum","volume":"23","author":"San Sebastian","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib46","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/mt.2010.106","article-title":"Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC","volume":"18","author":"Hadaczek","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib47","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.gt.3302011","article-title":"Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain","volume":"10","author":"Wang","year":"2003","journal-title":"Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib48","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1128\/JVI.76.15.7651-7660.2002","article-title":"Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size","volume":"76","author":"Yang","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mtm.2016.37_bib49","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mtm.2016.37_bib50","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1128\/JVI.00895-06","article-title":"Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6","volume":"80","author":"Wu","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mtm.2016.37_bib51","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1038\/mtm.2016.37_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2009.129","article-title":"The reward circuit: linking primate anatomy and human imaging","volume":"35","author":"Haber","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1038\/mtm.2016.37_bib54","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1523\/JNEUROSCI.22-18-08117.2002","article-title":"Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas","volume":"22","author":"McFarland","year":"2002","journal-title":"J Neurosci"},{"key":"10.1038\/mtm.2016.37_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(75)90384-4","article-title":"Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis","volume":"88","author":"K\u00fcnzle","year":"1975","journal-title":"Brain Res"},{"key":"10.1038\/mtm.2016.37_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymthe.2006.02.018","article-title":"The \u201cperivascular pump\u201d driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain","volume":"14","author":"Hadaczek","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mt.2015.35","article-title":"Transduction of antigen-presenting cells in the brain by AAV9 warrants caution in preclinical studies","volume":"23","author":"Forsayeth","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mtm.2016.37_bib58","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/mtm.2014.49","article-title":"Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of non-human primate","volume":"3","author":"San Sebastian","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1038\/mtm.2016.37_bib59","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/gt.2013.48","article-title":"Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain","volume":"20","author":"San Sebastian","year":"2013","journal-title":"Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib60","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mtm.2016.37_bib61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/hum.2009.070","article-title":"Manufacturing recombinant adeno-associated viral vectors from producer cell clones","volume":"20","author":"Thorne","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtm.2016.37_bib62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hgtb.2013.046","article-title":"Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production","volume":"24","author":"Martin","year":"2013","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mtm.2016.37_bib63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jviromet.2006.11.019","article-title":"Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography","volume":"140","author":"Qu","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1038\/mtm.2016.37_bib64","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1525-0016(03)00095-9","article-title":"Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6","volume":"7","author":"Grimm","year":"2003","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:39:13Z","timestamp":1718671153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050117300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":64,"alternative-id":["S2329050117300116"],"URL":"https:\/\/doi.org\/10.1038\/mtm.2016.37","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"article-number":"16037"}}